Teniposide is a semisynthetic derivative of podophyllotoxin categorized as an antitumor agent primarily utilized in pediatric oncology for the treatment of conditions such as neuroblastoma, retinoblastoma,… Read more
Teniposide is a semisynthetic derivative of podophyllotoxin categorized as an antitumor agent primarily utilized in pediatric oncology for the treatment of conditions such as neuroblastoma, retinoblastoma, and various lymphomas. This category provides access to high-quality reference standards, including the active pharmaceutical ingredient, process-related impurities, and related degradation products essential for impurity profiling. Laboratories rely on these materials to develop and validate precise analytical methods for identifying and quantifying trace components in drug formulations. Additionally, stable isotope labelled compounds such as teniposide-d3 are included to serve as internal standards in mass spectrometry-based assays, ensuring accuracy in pharmacokinetic studies and metabolic research. These reference materials support rigorous quality control and regulatory compliance processes required for the characterization of this potent cytotoxic agent throughout the pharmaceutical development lifecycle.